Across TCGA pan-cancer cohorts, RNA5SP59 RNA is linked to patient survival in 3 of 34 cancer types, making it the most broadly survival-associated RNA5SP59 data layer.

The strongest signal is observed in acute myeloid leukemia (LAML), where higher RNA5SP59 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNA5SP59 expression acts as an unfavorable survival marker, although some lineages such as KIRC show a favorable association.

LAML, BLCA, and KIRC are the cancer types where RNA5SP59 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LAML	DFS	Tertile	All	0.096	0.591	<.001	36	view →
BLCA	OS	Tertile	All	0.164	0.609	.005	27	view →
KIRC	DFS	Tertile	II,III,IV	1.000	0.528	.047	6	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: RNA5SP59 tumor-vs-normal RNA expression · all RNA5SP59 data types